Sales and Marketing

Showing 15 posts of 11528 posts found.

Roche’s Tecentriq scores approvals in metastatic lung and bladder cancer

September 27, 2017 Research and Development, Sales and Marketing Cancer, EMA, EU, European Commission, Roche, bladder cancer, immunotherapy, lung cancer, pharma, tecentriq

It’s good news for Roche as the company’s immunotherapy drug Tecentriq secures approval from the European Commission to be used …

New CMO hops onto Bicycle Therapeutics

September 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bicycle Therapeutics, GSK, Pfizer, biotech, drugs, pharma, pharmaceutical

Bicycle Therapeutics has moved to appoint industry veteran, Maria Koehler, to the position of Chief Medical Officer at the company. …

Allergan’s Executive VP and Chief Financial Officer steps down

September 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, appointment

Allergan has announced that its Executive Vice President and Chief Financial Officer Tessa Hilado intends to step down from her …

FDA pointedly rejects Intellipharma’s opioid painkiller

September 26, 2017 Manufacturing and Production, Sales and Marketing FDA, Intellipharma, biotech, drugs, pharma, pharmaceutical

The FDA has been very public in its stance that it will look to gain the upper hand in bringing …

Pangea X: the largest coordinated operation against counterfeit drugs

September 26, 2017 Manufacturing and Production, Sales and Marketing Europol, FDA, biotech, drugs, interpol, pharma, pharmaceutical

Operation Pangea X represents an anniversary, of sorts – as it stands as the 10th year of operations by Interpol …

Pfizer sets up its own biotech to develop rejected drugs

September 26, 2017 Manufacturing and Production, Sales and Marketing Pfizer, SpringWorks Therapeutics, biotech, drugs, pharma, pharmaceutical

Pfizer has moved to set up an entirely independent company to develop four of its own clinical-stage drug candidates. The …

Refining the system: Improving patients’ access to medicine

September 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NCIE, drug access, eams, market access, pharma, pharmaceuticals

The MHRA and NICE have been slowly improving the ways that the UK’s patients access medicines, but now Brexit threatens …

Allergan posts disappointing data in NASH

September 25, 2017 Research and Development, Sales and Marketing Allergan, biotech, drugs, nash, pharma, pharmaceutical

It was only last year that Allergan decided to cough up $1.7 billion to acquire Tobira Therapeutics, with the main …

Sanofi’s arthritis treatment Kevzara secures NICE recommendation

September 25, 2017 Sales and Marketing Kevzara, NICE, Sanofi, pharma, pharmaceutical, rheumatoid arthritis, sarilumab

Sanofi, along with its speciality care global business unit Sanofi Genzyme, are celebrating the news that NICE has passed its …

‘Super malaria’ sweeps South East Asia

September 25, 2017 Medical Communications, Sales and Marketing biotech, drug resistance, drug-resistance, drugs, malaria, pharma, pharmaceutical

There has long been concern over cases of drug-resistant malaria emerging in Asia and now it has been revealed that …

Indivior reaches settlement with Mylan over patent dispute

September 25, 2017 Sales and Marketing Mylan, indivior, patent, pharma, pharmaceutical, suboxone

Indivior has ended a patent dispute with Mylan concerning its heroin addiction therapy Suboxone (buprenorphine and naloxone) sublingual film by …

FDA rejects J&J’s treatment for rheumatoid arthritis

September 25, 2017 Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical, sirukumab

Perhaps unsurprisingly, after the FDA’s advisory committee had voted 12-1 against approval of Johnson & Johnson’s drug, the FDA returned …

Top Ten most popular articles on Pharmafile.com this week

September 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s been a great week for drug research and access, with the first-ever FDA approval of a biosimilar in cancer …

19 deaths from liver drug causes Intercept shares to tumble

September 22, 2017 Medical Communications, Sales and Marketing Intercept Pharmaceuticals, Ocliva, biotech, drugs, pharma, pharmaceutical

Intercept Pharmaceuticals had sparked major concerns over its drug, Ocaliva, after it revealed that 10 people had died as a …
The Gateway to Local Adoption Series

Latest content